Stay updated on Abaloparatide-Solid Microstructured Transdermal System Clinical Trial
Sign up to get notified when there's something new on the Abaloparatide-Solid Microstructured Transdermal System Clinical Trial page.

Latest updates to the Abaloparatide-Solid Microstructured Transdermal System Clinical Trial page
- Check3 days agoChange DetectedAdded a system notice about government funding lapse and NIH operations, and updated the site version from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check10 days agoChange DetectedUI updates add a Show glossary option and normalize capitalization for QC-related labels (Last Update Submitted that Met QC Criteria) and No FEAR Act Data, plus a new Revision: v3.4.0 note. The previous labels (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4) are removed.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedFooter revision updated from v3.3.3 to v3.3.4; this is a minor version change and does not affect study details or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check46 days agoChange DetectedLocations section updated: new state entries added and existing state entries removed. This changes which sites are listed for the study and where potential participants can enroll.SummaryDifference2%

- Check74 days agoChange DetectedPublications section wording updated to indicate PubMed automatically populates entries and may not reflect the study; site footer revision updated to v3.3.2.SummaryDifference0.1%

- Check82 days agoChange DetectedRemoved the government funding notice about potential delays and operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Abaloparatide-Solid Microstructured Transdermal System Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Abaloparatide-Solid Microstructured Transdermal System Clinical Trial page.